Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Antipsychotic drugs and obesity.

Correll CU, Lencz T, Malhotra AK.

Trends Mol Med. 2011 Feb;17(2):97-107. doi: 10.1016/j.molmed.2010.10.010. Epub 2010 Dec 22. Review.

2.

Pharmacogenetics of antipsychotic-induced weight gain.

Correll CU, Malhotra AK.

Psychopharmacology (Berl). 2004 Aug;174(4):477-89. Epub 2004 Jul 8. Review.

PMID:
15243737
3.

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.

Malhotra AK, Correll CU, Chowdhury NI, Müller DJ, Gregersen PK, Lee AT, Tiwari AK, Kane JM, Fleischhacker WW, Kahn RS, Ophoff RA, Meltzer HY, Lencz T, Kennedy JL.

Arch Gen Psychiatry. 2012 Sep;69(9):904-12.

4.

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.

Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Müller DJ.

Mol Psychiatry. 2012 Mar;17(3):242-66. doi: 10.1038/mp.2011.109. Epub 2011 Sep 6. Review.

PMID:
21894153
5.

Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.

Gregoor JG, van der Weide J, Mulder H, Cohen D, van Megen HJ, Egberts AC, Heerdink ER.

J Clin Psychopharmacol. 2009 Feb;29(1):21-5. doi: 10.1097/JCP.0b013e31819359be.

PMID:
19142102
6.

Susceptibility genes for the side effect of antipsychotics on body weight and obesity.

Chagnon YC.

Curr Drug Targets. 2006 Dec;7(12):1681-95. Review.

PMID:
17168843
7.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
8.

Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications.

Lee AK, Bishop JR.

Pharmacogenomics. 2011 Jul;12(7):999-1016. doi: 10.2217/pgs.11.45. Review.

9.

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

Stahl SM, Mignon L, Meyer JM.

Acta Psychiatr Scand. 2009 Mar;119(3):171-9. doi: 10.1111/j.1600-0447.2008.01334.x. Review.

PMID:
19178394
10.

[Antipsychotic-induced weight gain--pharmacogenetic studies].

Olajossy-Hilkesberger L, Godlewska B, Marmurowska-Michałowskal H, Olajossy M, Landowski J.

Psychiatr Pol. 2006 Sep-Oct;40(5):1009-20. Review. Polish.

PMID:
17217242
11.

Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment.

Perez-Iglesias R, Mata I, Amado JA, Berja A, Garcia-Unzueta MT, Martínez García O, Arranz MJ, Vazquez-Barquero JL, Crespo-Facorro B.

J Clin Psychopharmacol. 2010 Dec;30(6):661-6.

PMID:
21105276
12.

Management of antipsychotic-related weight gain.

Maayan L, Correll CU.

Expert Rev Neurother. 2010 Jul;10(7):1175-200. doi: 10.1586/ern.10.85. Review.

13.
14.

Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin.

Jin H, Meyer JM, Mudaliar S, Jeste DV.

Schizophr Res. 2008 Mar;100(1-3):70-85. doi: 10.1016/j.schres.2007.11.026. Epub 2008 Jan 18. Review.

15.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
16.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
17.

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

Le Hellard S, Theisen FM, Haberhausen M, Raeder MB, Fernø J, Gebhardt S, Hinney A, Remschmidt H, Krieg JC, Mehler-Wex C, Nöthen MM, Hebebrand J, Steen VM.

Mol Psychiatry. 2009 Mar;14(3):308-17. doi: 10.1038/sj.mp.4002133. Epub 2008 Jan 15.

PMID:
18195716
18.

Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.

Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL.

J Clin Psychiatry. 2001;62 Suppl 23:45-66. Review.

PMID:
11603885
19.

Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting.

Gregoor JG, van der Weide J, Loovers HM, van Megen HJ, Egberts TC, Heerdink ER.

Pharmacogenomics. 2011 Jun;12(6):919-23. doi: 10.2217/pgs.11.40. Epub 2011 Apr 21.

PMID:
21510767
20.

Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.

Reynolds GP, Kirk SL.

Pharmacol Ther. 2010 Jan;125(1):169-79. doi: 10.1016/j.pharmthera.2009.10.010. Epub 2009 Nov 17. Review.

PMID:
19931306
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk